Novartis Reports Results of Trial Evaluating Use of Afinitor By: Benzinga via Benzinga December 12, 2014 at 08:34 AM EST Novartis announces results of trial evaluating the use of Afinitor® in first-line treatment in HER2+ advanced breast cancer at SABCS . ... Read More >> Related Stocks: Novartis Ag ADR